[1]
2022. Use of Nusinersen in type 1 Spinal Muscular Atrophy. Literature Review . Research, Society and Development. 11, 4 (Mar. 2022), e33811427297. DOI:https://doi.org/10.33448/rsd-v11i4.27297.